Medicare Enrolled

Dr. Jason Rand, PA

Physician Assistant · Waltham, MA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
840 WINTER ST, Waltham, MA 02451
7818902133
In practice since 2006 (20 years)
NPI: 1417937137 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rand from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rand? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rand

Dr. Jason Rand is a physician assistant in Waltham, MA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Rand performed 8,284 Medicare services across 913 unique beneficiaries.

Between the years covered by Open Payments, Dr. Rand received a total of $92,259 from 17 pharmaceutical and/or device companies across 206 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in physician assistant. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rand is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 1% volume in MA $92,259 industry payments

Medicare Practice Summary

Medicare Utilization ↗
8,284
Medicare services
Top 1% in MA for physician assistant
913
Unique beneficiaries
$21
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~414 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Extended-release steroid injection (Zilretta)
An injection of triamcinolone acetonide using a preservative-free, extended-release microsphere formulation. The dosage is measured in milligrams.
5,121 $13 $47
Joint lubricant injection (Durolane)
An injection of hyaluronan or its derivative, specifically Durolane, administered directly into a joint space.
1,741 $5 $42
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
430 $62 $225
Ultrasound-guided large joint aspiration or injection
This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint.
424 $80 $561
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
223 $1 $40
Hyaluronan injection (Euflexxa) for joint
An injection of hyaluronan or its derivative, specifically Euflexxa, administered directly into a joint space.
177 $99 $270
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
94 $78 $575
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
36 $48 $325
Hyaluronan intra-articular injection
An injection of hyaluronan or a derivative into a joint to provide lubrication and cushioning.
20 $564 $2,500
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
18 $88 $325
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$92,259
Total received (2021-2024)
Avg $23,065/year across 4 years
Top 0% in MA for physician assistant
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
17
Companies
206
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$65,622 (71.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$15,933 (17.3%)
Other
Charitable contributions, space rental, and other categories
$5,976 (6.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,728 (5.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$16,014
2023
$23,070
2022
$20,307
2021
$32,867

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Pacira Pharmaceuticals Incorporated
$8,183
Vericel Corporation
$7,320
DePuy Synthes Sales Inc.
$212
Smith+Nephew, Inc.
$144
VERTEX PHARMACEUTICALS INCORPORATED
$64
Bioventus LLC
$54
AXOGEN
$19
Ferring Pharmaceuticals Inc.
$17
Top 3 companies account for 98.1% of 2024 payments
All-time payments by company (2021-2024) ›
Pacira Therapeutics, Inc.
$32,043
Pacira Pharmaceuticals Incorporated
$26,628
Vericel Corporation
$23,415
Anika Therapeutics, Inc.
$5,976
Kairos Surgical Inc
$2,592
Bioventus LLC
$482
DePuy Synthes Sales Inc.
$264
Orthofix Medical, Inc.
$178
Ferring Pharmaceuticals Inc.
$149
Smith+Nephew, Inc.
$144
Stryker Corporation
$128
Planmeca USA, Inc.
$72
VERTEX PHARMACEUTICALS INCORPORATED
$64
Arthrex, Inc.
$42
Fidia Pharma USA Inc.
$41
Integra LifeSciences Corporation
$23
AXOGEN
$19
Top 3 companies account for 89.0% of all-time payments
Associated products mentioned in payments ›
Avance Nerve Graft · DUROLANE · Durolane · EUFLEXXA · Exogen Ultrasound Bone Healing System · Exparel · HYMOVIS · INSPACE · Iovera · Iovera System · MACI · MONOVISC · ORTHOVISC · PICO · PLANMECA EMERALD S · PLANMECA PROMAX · Physio-Stim · TENOGLIDE · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (71%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in physician assistant and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for physician assistant in MA.

Looking for a physician assistant in Waltham?
Compare physician assistants in the Waltham area by procedure volume, costs, and industry payment transparency.
Browse physician assistants nearby

Geographic Context

Physician assistants within 10 mi
2,760
Per 100K population
170.1
County median income
$126,779
Nearest hospital
MCLEAN HOSPITAL CORPORATION
3.7 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Rand is a mixed practice specialist, with above-average Medicare volume (top 1% in MA), with speaking/promotional industry engagement in the top 0% of MA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Rand experienced with extended-release steroid injection (zilretta)?
Based on Medicare claims data, Dr. Rand performed 5,121 extended-release steroid injection (zilretta) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rand receive payments from pharmaceutical companies?
Yes. Dr. Rand received a total of $92,259 from 17 companies across 206 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rand's costs compare to other physician assistants in Waltham?
Dr. Rand's average Medicare payment per service is $21. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rand) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →